Literature DB >> 26254004

Analysis and meta-analysis of five polymorphisms of the LINGO1 and LINGO2 genes in Parkinson's disease and multiple system atrophy in a Chinese population.

YongPing Chen1, Bei Cao1, Jing Yang1, QianQian Wei1, Ru Wei Ou1, Bi Zhao1, Wei Song1, XiaoYan Guo1, HuiFang Shang2.   

Abstract

Whether polymorphisms rs11856808 and rs9652490 of the Leucine-rich repeat and Ig domain containing, Nogo receptor-interacting protein-1 (LINGO1) gene, as well as rs10968280, rs13362909 and rs7033345 of the LINGO2 gene, increase the risk for Parkinson's disease (PD) is controversial. Considering the overlap of the clinical and pathological characteristics among PD and multiple system atrophy (MSA), we explored the associations between these five polymorphisms and PD and MSA in a Chinese population. A total of 1055 PD patients, 320 MSA patients, and 810 healthy controls (HCs) were genotyped for these five polymorphisms in LINGO1 and LINGO 2 using Sequenom iPLEX Assay technology. Moreover, after combining our results with available published data, a meta-analysis was conducted to investigate the associations between LINGO 1 rs11856808 and rs9652490 and the risk of PD. The frequency of the minor alleles "T" of LINGO1 rs11856808 was significantly lower in PD than that in HCs (p = 0.011, OR 0.89, 95 % CI 0.81-0.97), but not in MSA. Moreover, there were no significant differences in the minor allele frequency distributions of the other four polymorphisms between PD and HCs, and between MSA and HCs. The meta-analysis showed a lack of association of rs9652490 and PD, regardless of the genetic model or ethnic origin. However, the rs11856808 allele decreased the risk of PD in patients of Asian origin in a dominant genetic model. Our findings suggest that rs11856808 plays a protective role by decreasing the risk for PD, but not for MSA, in Asian population, the other four polymorphisms do not contribute to the risk for PD and MSA.

Entities:  

Keywords:  LINGO1; LINGO2; Multiple system atrophy; Parkinson’s disease; Polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 26254004     DOI: 10.1007/s00415-015-7870-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.

Authors:  Sha Mi; Xinhua Lee; Zhaohui Shao; Greg Thill; Benxiu Ji; Jane Relton; Melissa Levesque; Norm Allaire; Steve Perrin; Bryan Sands; Thomas Crowell; Richard L Cate; John M McCoy; R Blake Pepinsky
Journal:  Nat Neurosci       Date:  2004-02-15       Impact factor: 24.884

2.  Genetic model testing and statistical power in population-based association studies of quantitative traits.

Authors:  Guillaume Lettre; Christoph Lange; Joel N Hirschhorn
Journal:  Genet Epidemiol       Date:  2007-05       Impact factor: 2.135

3.  Lingo2 variants associated with essential tremor and Parkinson's disease.

Authors:  Yi-Wen Wu; K M Prakash; Tian-Yi Rong; Hui-Hua Li; Qin Xiao; Louis C Tan; Wing-Lok Au; Jian-qing Ding; Sheng-di Chen; Eng-King Tan
Journal:  Hum Genet       Date:  2011-02-02       Impact factor: 4.132

4.  Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo.

Authors:  Shunsaku Homma; Takako Shimada; Tsuyoshi Hikake; Hiroyuki Yaginuma
Journal:  Gene Expr Patterns       Date:  2008-09-21       Impact factor: 1.224

5.  SNCA variants rs2736990 and rs356220 as risk factors for Parkinson's disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.

Authors:  Xiao Yan Guo; Yong Ping Chen; Wei Song; Bi Zhao; Bei Cao; Qian Qian Wei; Ru Wei Ou; Yuan Yang; Li Xing Yuan; Hui-Fang Shang
Journal:  Neurobiol Aging       Date:  2014-07-18       Impact factor: 4.673

6.  LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease.

Authors:  Carles Vilariño-Güell; Christian Wider; Owen A Ross; Barbara Jasinska-Myga; Jennifer Kachergus; Stephanie A Cobb; Alexandra I Soto-Ortolaza; Bahareh Behrouz; Michael G Heckman; Nancy N Diehl; Claudia M Testa; Zbigniew K Wszolek; Ryan J Uitti; Joseph Jankovic; Elan D Louis; Lorraine N Clark; Alex Rajput; Matthew J Farrer
Journal:  Neurogenetics       Date:  2010-04-06       Impact factor: 2.660

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  LINGO1 rs9652490 variant in Parkinson disease patients.

Authors:  Yi Guo; Joseph Jankovic; Zhi Song; Huarong Yang; Wen Zheng; Weidong Le; Xiangqi Tang; Xiong Deng; Yan Yang; Sheng Deng; Ziqiang Luo; Hao Deng
Journal:  Neurosci Lett       Date:  2010-10-15       Impact factor: 3.046

9.  Role of LINGO1 polymorphisms in Parkinson's disease.

Authors:  Dietrich Haubenberger; Christoph Hotzy; Walter Pirker; Regina Katzenschlager; Thomas Brücke; Fritz Zimprich; Eduard Auff; Alexander Zimprich
Journal:  Mov Disord       Date:  2009-12-15       Impact factor: 10.338

10.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

View more
  8 in total

1.  Proteomic Investigation of Murine Neuronal α7-Nicotinic Acetylcholine Receptor Interacting Proteins.

Authors:  Matthew J Mulcahy; Joao A Paulo; Edward Hawrot
Journal:  J Proteome Res       Date:  2018-10-04       Impact factor: 4.466

2.  Spatiotemporal and Long Lasting Modulation of 11 Key Nogo Signaling Genes in Response to Strong Neuroexcitation.

Authors:  Tobias E Karlsson; Katrin Wellfelt; Lars Olson
Journal:  Front Mol Neurosci       Date:  2017-04-11       Impact factor: 5.639

Review 3.  An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention.

Authors:  Viorica Chelban; Daniela Catereniuc; Daniela Aftene; Alexandru Gasnas; Ekawat Vichayanrat; Valeria Iodice; Stanislav Groppa; Henry Houlden
Journal:  J Neurol       Date:  2020-05-20       Impact factor: 4.849

4.  Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach.

Authors:  Tainá M Marques; Anouke van Rumund; Iris Kersten; Ilona B Bruinsma; Hans J C T Wessels; Jolein Gloerich; Charlotte Kaffa; Rianne A J Esselink; Bastiaan R Bloem; H Bea Kuiperij; Marcel M Verbeek
Journal:  NPJ Parkinsons Dis       Date:  2021-11-30

5.  Exploring the Genomic Patterns in Human and Mouse Cerebellums Via Single-Cell Sequencing and Machine Learning Method.

Authors:  ZhanDong Li; Deling Wang; HuiPing Liao; ShiQi Zhang; Wei Guo; Lei Chen; Lin Lu; Tao Huang; Yu-Dong Cai
Journal:  Front Genet       Date:  2022-03-04       Impact factor: 4.599

6.  VGF function in depression and antidepressant efficacy.

Authors:  C Jiang; W-J Lin; M Sadahiro; B Labonté; C Menard; M L Pfau; C A Tamminga; G Turecki; E J Nestler; S J Russo; S R Salton
Journal:  Mol Psychiatry       Date:  2017-11-21       Impact factor: 15.992

Review 7.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  LINGO-1 regulates Wnt5a signaling during neural stem and progenitor cell differentiation by modulating miR-15b-3p levels.

Authors:  Chen-Guang Zhao; Jie Qin; Jia Li; Shan Jiang; Fen Ju; Wei Sun; Zhen Ren; Yu-Qiang Ji; Rui Wang; Xiao-Long Sun; Xiang Mou; Hua Yuan
Journal:  Stem Cell Res Ther       Date:  2021-06-29       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.